Botulinum Toxin for Chronic Exertional Compartment Syndrome: A Case Report With 14 Month Follow-Up

Michael R. Baria, Jacob L. Sellon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

ABSTRACT:: Chronic exertional compartment syndrome (CECS) presents a unique therapeutic challenge. Fasciotomy, currently the most well accepted treatment approach, still has a significant number of treatment failures, demonstrating the need for additional options. Botulinum toxin has been introduced as a potential therapeutic agent, but long-term outcomes are unknown. We present the longest documented follow-up (14 months) of a CECS case treated with botulinum toxin injections. At 14 months follow-up, the patient reported continued pain relief and had resumed her active lifestyle without any adverse effects. Although more research is needed to optimize patient selection and treatment protocol, this case illustrates the potential for botulinum toxin as a long duration, low risk alternative treatment option for CECS.

Original languageEnglish (US)
JournalClinical Journal of Sport Medicine
DOIs
StateAccepted/In press - Jan 16 2016

Fingerprint

Compartment Syndromes
Botulinum Toxins
Therapeutics
Clinical Protocols
Treatment Failure
Patient Selection
Life Style
Pain
Injections
Research

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Botulinum Toxin for Chronic Exertional Compartment Syndrome : A Case Report With 14 Month Follow-Up. / Baria, Michael R.; Sellon, Jacob L.

In: Clinical Journal of Sport Medicine, 16.01.2016.

Research output: Contribution to journalArticle

@article{9505e63f53ca4cd881c44b83b9ecd6cd,
title = "Botulinum Toxin for Chronic Exertional Compartment Syndrome: A Case Report With 14 Month Follow-Up",
abstract = "ABSTRACT:: Chronic exertional compartment syndrome (CECS) presents a unique therapeutic challenge. Fasciotomy, currently the most well accepted treatment approach, still has a significant number of treatment failures, demonstrating the need for additional options. Botulinum toxin has been introduced as a potential therapeutic agent, but long-term outcomes are unknown. We present the longest documented follow-up (14 months) of a CECS case treated with botulinum toxin injections. At 14 months follow-up, the patient reported continued pain relief and had resumed her active lifestyle without any adverse effects. Although more research is needed to optimize patient selection and treatment protocol, this case illustrates the potential for botulinum toxin as a long duration, low risk alternative treatment option for CECS.",
author = "Baria, {Michael R.} and Sellon, {Jacob L.}",
year = "2016",
month = "1",
day = "16",
doi = "10.1097/JSM.0000000000000289",
language = "English (US)",
journal = "Clinical Journal of Sport Medicine",
issn = "1050-642X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Botulinum Toxin for Chronic Exertional Compartment Syndrome

T2 - A Case Report With 14 Month Follow-Up

AU - Baria, Michael R.

AU - Sellon, Jacob L.

PY - 2016/1/16

Y1 - 2016/1/16

N2 - ABSTRACT:: Chronic exertional compartment syndrome (CECS) presents a unique therapeutic challenge. Fasciotomy, currently the most well accepted treatment approach, still has a significant number of treatment failures, demonstrating the need for additional options. Botulinum toxin has been introduced as a potential therapeutic agent, but long-term outcomes are unknown. We present the longest documented follow-up (14 months) of a CECS case treated with botulinum toxin injections. At 14 months follow-up, the patient reported continued pain relief and had resumed her active lifestyle without any adverse effects. Although more research is needed to optimize patient selection and treatment protocol, this case illustrates the potential for botulinum toxin as a long duration, low risk alternative treatment option for CECS.

AB - ABSTRACT:: Chronic exertional compartment syndrome (CECS) presents a unique therapeutic challenge. Fasciotomy, currently the most well accepted treatment approach, still has a significant number of treatment failures, demonstrating the need for additional options. Botulinum toxin has been introduced as a potential therapeutic agent, but long-term outcomes are unknown. We present the longest documented follow-up (14 months) of a CECS case treated with botulinum toxin injections. At 14 months follow-up, the patient reported continued pain relief and had resumed her active lifestyle without any adverse effects. Although more research is needed to optimize patient selection and treatment protocol, this case illustrates the potential for botulinum toxin as a long duration, low risk alternative treatment option for CECS.

UR - http://www.scopus.com/inward/record.url?scp=84954476880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954476880&partnerID=8YFLogxK

U2 - 10.1097/JSM.0000000000000289

DO - 10.1097/JSM.0000000000000289

M3 - Article

C2 - 26784120

AN - SCOPUS:84954476880

JO - Clinical Journal of Sport Medicine

JF - Clinical Journal of Sport Medicine

SN - 1050-642X

ER -